Skip to content

Stem Cell Therapy for Hair Loss (Androgenetic Alopecia): Evidence, Cost & Trials (2026)

About this guide: We are independent patient researchers, not medical doctors. We review peer-reviewed literature (PubMed), government trial registries and regulators’ guidance, plus documented patient reports, to help you navigate clinic options and spot predatory marketing. How we research.

Androgenetic alopecia, also called male- or female-pattern hair loss, is the most common type of hair loss. It happens when hair follicles slowly shrink under the influence of hormones and genetics, producing thinner, shorter hairs. Researchers are testing whether cells from fat or hair follicles, or the signalling particles they release (exosomes and ‘conditioned media’), can wake up shrinking follicles.

AT A GLANCE · HAIR LOSS

Evidence levelEarly research
Approved stem cell treatment?No stem cell, stromal vascular fraction or exosome product is approved for hair loss by the US FDA, the European EMA, or regulators in Japan or Korea.
Typical private price$1,500 – $15,000 (indicative)
Recruiting trials5 listed on ClinicalTrials.gov (4 October 2026)
Last reviewedOctober 2026

Does stem cell therapy work for hair loss?

A 2023 systematic review of human studies found 15 studies with about 650 patients that used hair follicle-derived cells, fat-derived (adipose) cells or stromal vascular fraction, and reported hair density gains of roughly 15% to 50%. However, only five were randomised controlled trials, only nine had any control group, treatment methods differed widely, and the authors said results should be interpreted with caution until reproduced. A 2025 systematic review of exosome treatments for hair found 11 clinical studies with about 300 people, mostly small single-arm or retrospective reports with only two randomised trials, and called for well-standardised, high-quality trials.

Few studies have compared these approaches directly with proven medicines such as minoxidil or finasteride, and long-term results beyond a year are scarce. PRP (platelet-rich plasma) is often confused with stem cell treatment: it uses concentrated platelets from your own blood, not cells or exosomes, and has more randomised trials behind it, although its benefits are still modest and variable. Overall, cell-based and exosome hair treatments look reasonably safe in short studies but remain experimental.

Is any stem cell treatment approved for hair loss?

No stem cell, stromal vascular fraction or exosome product is approved for hair loss by the US FDA, the European EMA, or regulators in Japan or Korea. In December 2019 the FDA warned that there are no FDA-approved exosome products and reported serious adverse events in patients treated with unapproved exosome products. The FDA-approved medicines for pattern hair loss are topical minoxidil and, for men, oral finasteride.

What private clinics offer — and how it compares

Hair clinics and med-spas widely sell ‘stem cell’ or exosome scalp injections, often combined with PRP or microneedling, as a natural way to regrow hair or avoid a transplant. The research so far is small, short and mostly uncontrolled, and many products sold as exosomes are not standardised or approved, so results and safety cannot be guaranteed.

Proven treatments to discuss first

Before paying for an experimental option, make sure you have explored the established treatments for hair loss with your doctor:

  • Topical minoxidil (FDA-approved for men and women)
  • Oral finasteride for men (FDA-approved), after discussing side effects with a doctor
  • Low-level laser (light) devices cleared by the FDA for hair growth
  • Platelet-rich plasma (PRP) injections, which have more trial evidence than stem cell or exosome products
  • Hair transplant surgery for suitable candidates
  • Medical check for treatable causes such as thyroid problems, iron deficiency or medication side effects

How much does stem cell therapy for hair loss cost?

Private clinics typically quote $1,500 to $15,000. Price guides from medical-travel and hair clinic sites list exosome scalp sessions from about $1,500 and fat-derived stem cell hair procedures at roughly $3,000 abroad to $10,000-$20,000 in the US, often with repeat sessions advised. Figures vary widely and are not covered by insurance. Compare prices by country in our cost guide and location guides, and check insurance coverage.

Risks and side effects

  • Infection, scarring or lumps at fat-harvest or scalp injection sites
  • Pain, bruising and swelling, sometimes needing local anaesthesia or liposuction
  • Contaminated or poorly made products, especially unregulated exosome or donor-cell products
  • Delayed use of proven treatments while hair loss continues
  • High, repeated out-of-pocket costs for top-up sessions

Recruiting clinical trials for hair loss

On 4 October 2026, ClinicalTrials.gov listed 5 recruiting or soon-to-recruit stem cell studies for this condition. Here are up to eight, latest-stage first:

See all matching studies on ClinicalTrials.gov. A listing is not an endorsement: registration does not mean a study is safe or effective, and genuine trials rarely charge you for the experimental treatment. Ask the study team about costs, placebo groups and follow-up before you enrol. See our clinical trials hub.

Questions to ask before you agree to treatment

  1. What exactly is injected: my own fat or follicle cells, donor cells, exosomes or PRP?
  2. What results have you measured in your own patients, and how do they compare with minoxidil or finasteride?
  3. How many sessions will I need, and what happens to my hair if I stop?
  4. Is this product FDA-approved or used under an FDA investigational application (IND) number?
Before You Pay: The Stem Cell Clinic Checklist – free 9-page PDF
Free patient guide

Before You Pay: The Stem Cell Clinic Checklist

  • 20 questions every legitimate clinic should answer in writing
  • A red-flag scorecard to spot unregulated marketing
  • Realistic 2026 cost ranges: US, Mexico, Panama & Europe
  • How to find a registered clinical trial

We’ll email you a link to confirm. No spam, unsubscribe any time. See our Privacy Policy.

Red flags to watch for

  • Promises to regrow a full head of hair or replace the need for any other treatment
  • Selling ‘exosomes’ or donor ‘stem cells’ with no product testing records or FDA application number
  • Discouraging you from using minoxidil or finasteride before trying their package

Stem cell therapy for hair loss: FAQs

Does stem cell therapy work for hair loss?

Small studies report increases in hair density after fat- or follicle-derived cell treatments, but most lack proper control groups and use different methods. It is not yet proven to work better than standard treatments. Larger, well-designed trials are needed.

What is the difference between stem cell therapy and PRP for hair?

PRP uses platelets concentrated from your own blood, while stem cell treatments use cells taken from fat or hair follicles, or donor-derived products such as exosomes. PRP has more randomised trials, although its effect is still modest. Neither is an FDA-approved drug for hair loss.

Is stem cell or exosome hair treatment FDA approved?

No. The FDA has not approved any stem cell or exosome product for hair loss and warned in 2019 that no exosome products are approved. The FDA-approved medicines are topical minoxidil and, for men, oral finasteride.

How much does stem cell hair treatment cost?

Prices range from about $1,500 for a single exosome session to $10,000 or more for fat-derived cell procedures in the US. Clinics often recommend repeat sessions, so total costs can climb.

How long do stem cell hair results last?

Most studies follow patients for only six to twelve months, so long-term durability is unknown. Because pattern hair loss is ongoing, any gains may fade without continued treatment.

Related guides

Sources

Last reviewed October 2026. For general information only — not medical advice. We do not endorse any clinic or product. Always consult a qualified, licensed healthcare professional. See our medical disclaimer and editorial policy.